178 related articles for article (PubMed ID: 26088554)
1. Intermittent presumptive treatment in pregnancy with sulfadoxine-pyrimethamine: a counter perspective.
Nosten F; McGready R
Malar J; 2015 Jun; 14():248. PubMed ID: 26088554
[TBL] [Abstract][Full Text] [Related]
2. Intermittent preventive treatment of malaria in pregnancy: a cross-sectional survey to assess uptake of the new sulfadoxine-pyrimethamine five dose policy in Ghana.
Owusu-Boateng I; Anto F
Malar J; 2017 Aug; 16(1):323. PubMed ID: 28797296
[TBL] [Abstract][Full Text] [Related]
3. Impact of intermittent preventive treatment of malaria in pregnancy with dihydroartemisinin-piperaquine versus sulfadoxine-pyrimethamine on the incidence of malaria in infancy: a randomized controlled trial.
Kakuru A; Jagannathan P; Kajubi R; Ochieng T; Ochokoru H; Nakalembe M; Clark TD; Ruel T; Staedke SG; Chandramohan D; Havlir DV; Kamya MR; Dorsey G
BMC Med; 2020 Aug; 18(1):207. PubMed ID: 32772921
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of intermittent preventive treatment with sulphadoxine-pyrimethamine (IPTp-SP) use during pregnancy and other associated factors in Sekondi-Takoradi, Ghana.
Orish VN; Onyeabor OS; Boampong JN; Afoakwah R; Nwaefuna E; Acquah S; Sanyaolu AO; Iriemenam NC
Afr Health Sci; 2015 Dec; 15(4):1087-96. PubMed ID: 26958008
[TBL] [Abstract][Full Text] [Related]
5. Economic evaluation of an alternative drug to sulfadoxine-pyrimethamine as intermittent preventive treatment of malaria in pregnancy.
Sicuri E; Fernandes S; Macete E; González R; Mombo-Ngoma G; Massougbodgi A; Abdulla S; Kuwawenaruwa A; Katana A; Desai M; Cot M; Ramharter M; Kremsner P; Slustker L; Aponte J; Hanson K; Menéndez C
PLoS One; 2015; 10(4):e0125072. PubMed ID: 25915616
[TBL] [Abstract][Full Text] [Related]
6. Intermittent preventive treatment of malaria in pregnancy: at the crossroads of public health policy.
Chico RM; Chandramohan D
Trop Med Int Health; 2011 Jul; 16(7):774-85. PubMed ID: 21477099
[TBL] [Abstract][Full Text] [Related]
7. From evidence to action? Challenges to policy change and programme delivery for malaria in pregnancy.
Crawley J; Hill J; Yartey J; Robalo M; Serufilira A; Ba-Nguz A; Roman E; Palmer A; Asamoa K; Steketee R
Lancet Infect Dis; 2007 Feb; 7(2):145-55. PubMed ID: 17251085
[TBL] [Abstract][Full Text] [Related]
8. Intermittent treatment for the prevention of malaria during pregnancy in Benin: a randomized, open-label equivalence trial comparing sulfadoxine-pyrimethamine with mefloquine.
Briand V; Bottero J; Noël H; Masse V; Cordel H; Guerra J; Kossou H; Fayomi B; Ayemonna P; Fievet N; Massougbodji A; Cot M
J Infect Dis; 2009 Sep; 200(6):991-1001. PubMed ID: 19656069
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of Nigerian women taking sulfadoxine/pyrimethamine twice during pregnancy for the prevention of malaria.
Onyeneho NG; Orji BC; Okeibunor JC; Brieger WR
Int J Gynaecol Obstet; 2013 Nov; 123(2):101-4. PubMed ID: 24041469
[TBL] [Abstract][Full Text] [Related]
10. Intermittent preventive treatment with sulfadoxine-pyrimethamine against malaria and anemia in pregnant women.
Wilson NO; Ceesay FK; Obed SA; Adjei AA; Gyasi RK; Rodney P; Ndjakani Y; Anderson WA; Lucchi NW; Stiles JK
Am J Trop Med Hyg; 2011 Jul; 85(1):12-21. PubMed ID: 21734118
[TBL] [Abstract][Full Text] [Related]
11. The provider's checklist to improve pregnant women coverage by intermittent preventive malaria treatment in Mali: a pilot implementation study.
Doumbia I; Seydou F; Diakalia K; Bennis I
Malar J; 2021 Oct; 20(1):402. PubMed ID: 34656113
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of two versus three or more doses of intermittent preventive treatment for malaria during pregnancy in sub-Saharan Africa: a modelling study of meta-analysis and cost data.
Fernandes S; Sicuri E; Kayentao K; van Eijk AM; Hill J; Webster J; Were V; Akazili J; Madanitsa M; ter Kuile FO; Hanson K
Lancet Glob Health; 2015 Mar; 3(3):e143-53. PubMed ID: 25701992
[TBL] [Abstract][Full Text] [Related]
13. Effect of sulfadoxine-pyrimethamine resistance on the efficacy of intermittent preventive therapy for malaria control during pregnancy: a systematic review.
ter Kuile FO; van Eijk AM; Filler SJ
JAMA; 2007 Jun; 297(23):2603-16. PubMed ID: 17579229
[TBL] [Abstract][Full Text] [Related]
14. Intermittent Preventive Treatment with Sulfadoxine-Pyrimethamine: More Than Just an Antimalarial?
Gutman J; Slutsker L
Am J Trop Med Hyg; 2017 Jan; 96(1):9-10. PubMed ID: 27994102
[No Abstract] [Full Text] [Related]
15. Mortality, Morbidity, and Developmental Outcomes in Infants Born to Women Who Received Either Mefloquine or Sulfadoxine-Pyrimethamine as Intermittent Preventive Treatment of Malaria in Pregnancy: A Cohort Study.
Rupérez M; González R; Mombo-Ngoma G; Kabanywanyi AM; Sevene E; Ouédraogo S; Kakolwa MA; Vala A; Accrombessi M; Briand V; Aponte JJ; Manego Zoleko R; Adegnika AA; Cot M; Kremsner PG; Massougbodji A; Abdulla S; Ramharter M; Macete E; Menéndez C
PLoS Med; 2016 Feb; 13(2):e1001964. PubMed ID: 26905278
[TBL] [Abstract][Full Text] [Related]
16. Factors influencing adherence to the new intermittent preventive treatment of malaria in pregnancy policy in Keta District of the Volta region, Ghana.
Vandy AO; Peprah NY; Jerela JY; Titiati P; Manu A; Akamah J; Maya ET; Torpey K
BMC Pregnancy Childbirth; 2019 Nov; 19(1):424. PubMed ID: 31747927
[TBL] [Abstract][Full Text] [Related]
17. The impact of intermittent preventive treatment with sulfadoxine-pyrimethamine on the prevalence of malaria parasitaemia in pregnancy.
Umeh UA; Obi SN; Onah HE; Ugwu EO; Ajah LO; Umeh CR; Okafor II
Trop Doct; 2012 Jul; 42(3):133-5. PubMed ID: 22399105
[TBL] [Abstract][Full Text] [Related]
18. Intermittent preventive treatment for the prevention of malaria during pregnancy in high transmission areas.
Briand V; Cottrell G; Massougbodji A; Cot M
Malar J; 2007 Dec; 6():160. PubMed ID: 18053209
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of sulphadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy: a retrospective birth outcomes study in Mansa, Zambia.
Mace KE; Chalwe V; Katalenich BL; Nambozi M; Mubikayi L; Mulele CK; Wiegand RE; Filler SJ; Kamuliwo M; Craig AS; Tan KR
Malar J; 2015 Feb; 14():69. PubMed ID: 25890159
[TBL] [Abstract][Full Text] [Related]
20. Community-based promotional campaign to improve uptake of intermittent preventive antimalarial treatment in pregnancy in Burkina Faso.
Gies S; Coulibaly SO; Ky C; Ouattara FT; Brabin BJ; D'Alessandro U
Am J Trop Med Hyg; 2009 Mar; 80(3):460-9. PubMed ID: 19270299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
